TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization.

Ruben Niesvizky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.